Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study — A Randomized Clinical Trial. (vvs.vet)
In the QUEST Study, pimobendan significantly increased the survival time of dogs with congestive heart failure (CHF) caused by myxomatous mitral valve disease (MMVD). (epictrial.com)
The EPIC Study was the largest clinical study ever to be conducted amongst dogs with myxomatous mitral valve disease (MMVD). (epictrial.com)